Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
UWM Holdings
UWMC
$617M
| $2.78M | ﹤0.01% |
496,610
+1,684
| +0.3% | +$9.07K |
|
2452
RE/MAX Holdings
RMAX
$193M
| $2.78M | ﹤0.01% |
144,151
+2,768
| +2% | +$51.8K |
|
2453
Funko
FNKO
$326M
| $2.76M | ﹤0.01% |
255,354
+7,230
| +3% | +$79.6K |
|
2454
Tarsus Pharmaceuticals
TARS
$2.58B
| $2.76M | ﹤0.01% |
152,664
+13,513
| +10% | +$215K |
|
2455
Viridian Therapeutics
VRDN
$2.09B
| $2.75M | ﹤0.01% |
115,787
+11,717
| +11% | +$301K |
|
|
TBRG
2456
DELISTED
TruBridge
TBRG
| $2.72M | ﹤0.01% |
110,290
+1,022
| +0.9% | +$26.6K |
|
2457
ImmunityBio
IBRX
$7.51B
| $2.72M | ﹤0.01% |
978,547
+262,912
| +37% | +$743K |
|
2458
Frontier Group Holdings
ULCC
$1.55B
| $2.7M | ﹤0.01% |
279,537
+3,125
| +1% | +$28.1K |
|
|
MRSN
2459
DELISTED
Mersana Therapeutics
MRSN
| $2.7M | ﹤0.01% |
32,828
+3,641
| +12% | +$533K |
|
2460
Target Hospitality
TH
$1.51B
| $2.68M | ﹤0.01% |
199,866
+8,195
| +4% | +$113K |
|
|
SLGC
2461
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $2.68M | ﹤0.01% |
1,160,653
+33,947
| +3% | +$95.8K |
|
2462
Qfin Holdings
QFIN
$1.69B
| $2.68M | ﹤0.01% |
155,085
-2,156
| -1% | -$36.3K |
|
2463
First Financial Corp
THFF
$958M
| $2.67M | ﹤0.01% |
82,216
+1,138
| +1% | +$38.8K |
|
|
TUP
2464
DELISTED
Tupperware Brands Corporation
TUP
| $2.66M | ﹤0.01% |
3,330,763
+1,543,145
| +86% | +$1.67M |
|
2465
Excelerate Energy
EE
$1.25B
| $2.66M | ﹤0.01% |
130,765
-338
| -0.3% | -$7.06K |
|
2466
Ubiquiti
UI
$33.7B
| $2.66M | ﹤0.01% |
15,112
+539
| +4% | +$109K |
|
|
HONE
2467
DELISTED
HarborOne Bancorp
HONE
| $2.65M | ﹤0.01% |
305,296
-13,087
| -4% | -$125K |
|
2468
Organogenesis Holdings
ORGO
$305M
| $2.65M | ﹤0.01% |
798,166
+9,013
| +1% | +$26.6K |
|
2469
Greif Class B
GEF.B
$4.11B
| $2.65M | ﹤0.01% |
34,250
-406
| -1% | -$31K |
|
2470
Shell
SHEL
$254B
| $2.65M | ﹤0.01% |
43,812
+18,349
| +72% | +$1.1M |
|
2471
Preformed Line Products
PLPC
$1.74B
| $2.64M | ﹤0.01% |
16,931
+89
| +0.5% | +$13K |
|
2472
Pennant Group
PNTG
$1.4B
| $2.64M | ﹤0.01% |
214,955
+7,609
| +4% | +$96.7K |
|
2473
AstraZeneca
AZN
$263B
| $2.61M | ﹤0.01% |
18,204
+8,368
| +85% | +$1.23M |
|
|
FFIC
2474
DELISTED
Flushing Financial
FFIC
| $2.56M | ﹤0.01% |
208,457
+1,070
| +0.5% | +$13.5K |
|
2475
Phathom Pharmaceuticals
PHAT
$708M
| $2.56M | ﹤0.01% |
178,870
+7,263
| +4% | +$83.7K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.